ExploreWatchlistsPricing
  1. JP-listed companies
  2. SUZUKEN CO.,LTD.
  3. Financials
  4. EBITDA

SUZUKEN CO.,LTD. (9987)

Market cap
¥437.6B
P/E ratio
13.3x
Suzuken distributes prescription drugs, medical devices and diagnostic products to healthcare providers across Japan through a nationwide network of subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEBITDA (Million JPY)YoY (%)
Mar 31, 202549,178+13.21%
Mar 31, 202443,438+5.32%
Mar 31, 202341,244+76.73%
Mar 31, 202223,337+20.70%
Mar 31, 202119,335-55.34%
Mar 31, 202043,290+13.92%
Mar 31, 201938,000+23.47%
Mar 31, 201830,777+1.13%
Mar 31, 201730,432-24.25%
Mar 31, 201640,174+60.97%
Mar 31, 201524,958

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat